A Study to Investigate the Pharmacokinetics of ACT-1014-6470 in Subjects With Severe Renal Impairment Compared to Control Subjects
Clinical trial NCT04899219 · COMPLETED
Trial details
- NCT number
- NCT04899219
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-16
- Primary completion
- 2021-11-12
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.